Search For "covid 19 disease"
White blood cell count may predict severity of COVID-19: Study
Updated : 7 months, 4 weeks ago IST
A Covid-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.
Read More
Study shows that gut fungus has a long-term impact on the immunological re
Updated : 7 months, 4 weeks ago IST
According to a new study led by Weill Cornell Medicine and New York-Presbyterian, specific gut-dwelling fungi thrive in severe cases of COVID-19, exacerbating the disease's extreme inflammation while also causing long-term immune system changes.
Read More
Researchers reveal how depression, poor mental health connected with heart
Updated : 3 years, 4 months ago IST
According to a recent study, researchers found that examined data from more than 500,000 people between the ages of 18 and 49, young adults who experience sadness or depression are more likely to develop cardiovascular disease (CVD) and have poor heart health. The findings support a growing
Read More
Daily use of Cholesterol-lowering medicine related to a decrease in COVID-
Updated : 3 years, 7 months ago IST
New Orleans [US], October 23 (ANI): A research of over 38,000 people found that commonly used cholesterol-lowering statins may decrease the risk of mortality and the severity of COVID-19 disease.
Read More
Zambia to start administering oral antiviral COVID-19 pills
Updated : 3 years, 10 months ago IST
Lusaka [Zambia], July 8 (ANI/Xinhua): Zambia will soon start administering Paxlovid, an oral antiviral pill, to people at risk of developing severe COVID-19 disease, its health ministry said on Friday.
Read More
Research: Babies exposed to COVID in womb can display neurodevelopmental c
Updated : 3 years, 11 months ago IST
Washington [US], June 6 (ANI): Babies born to mothers who suffered COVID-19 disease during pregnancy seem to exhibit differences in neurodevelopmental outcomes in 6 weeks, according to a preliminary analysis.
Read More
Indore residents enthusiastic to celebrate Holi sans COVID-19 scare
Updated : 4 years, 2 months ago IST
Indore (Madhya Pradesh) [India], March 15 (ANI): With Holi round the corner, Indore residents are filled with enthusiasm and joy to celebrate the festival of colours without any fear of COVID-19 disease after two years.
Read More
People should learn to live with COVID-19: Top infectious disease expert D
Updated : 4 years, 4 months ago IST
New Delhi [India], January 19 (ANI): People should learn to live with COVID-19 disease and should not throw caution to the wind, said Dr Faheem Younus, Chief of Infectious Disease at the University of Maryland, on Tuesday.
Read More
People should learn to live with COVID-19: Top infectious disease expert D
Updated : 4 years, 4 months ago IST
New Delhi [India], January 19 (ANI): People should learn to live with COVID-19 disease and should not throw caution to the wind, said Dr Faheem Younus, Chief of Infectious Disease at the University of Maryland, on Tuesday.
Read More
Chandigarh announces Rs 50,000 ex gratia to kin of those who died of COVID
Updated : 4 years, 5 months ago IST
Chandigarh (Punjab) [India], December 10 (ANI): An ex-gratia amount of Rs 50,000 will be given to the next of kin of persons who died of COVID-19 disease, said Yashpal Garg, Secretary Health of Chandigarh on Thursday.
Read More
Jharkhand govt announces Rs 50,000 ex gratia to kins of persons dead due t
Updated : 4 years, 5 months ago IST
Ranchi (Jharkhand) [India], December 9 (ANI): Jharkhand Health and Disaster Management Minister Banna Gupta on Wednesday made an announcement of giving Rs 50,000 ex-gratia from the State Disaster Management Department Fund to the kin of persons who died of COVID-19 disease.
Read More
Covaxin 50 pc effective against symptomatic COVID: Lancet study
Updated : 4 years, 6 months ago IST
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Read More